新兴抗抑郁药物策略的分子机制:从胺到神经调节
Mateusz Kowalczyk1, David Aebisher2, Jakub Szpara3
1MediPsyche Medical Center, J. Kolinskiego 27, 91-849 Lodz, Poland.
International journal of molecular sciences
|January 10, 2026
概括
这篇评论探讨了抑郁症的治疗方法,从目前的药物如SSRI到针对神经递质系统的新疗法以及非药物方法如TMS. 它将这些策略与抑郁症联系在一起.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症在全球影响着3亿多人,构成了重大的医疗挑战.
- 病理生理学涉及遗传学,压力,HPA轴,神经炎症,氧化应激和塑性受损.
- 治疗耐药性和症状异质性需要先进的治疗策略.
研究的目的:
- 审查当前和新兴的药理和非药理抑郁症治疗方法.
- 强调这些疗法的细胞和分子作用机制.
- 整合治疗机制与抑郁症病理生理学,以准确,有针对性的战略.
主要方法:
- 来自PubMed,谷歌学者和clinicaltrials.gov.gov的文献综合
- 对已知抗抑郁药物 (SSRI,SNRI,TCA,MAOI) 的分析.
- 专注于针对谷氨酸,GABAergic和多巴胺基系统的新型药物,以及神经调节技术 (TMS,tDCS,光生物调节).
主要成果:
- 目前的抗抑郁药有其局限性.
- 新兴的疗法包括胺,DMX-BUP,神经类固醇,盖皮龙ER和卡里普拉.
- 像TMS,tDCS和光生物调制等非药理学方法提供了替代或辅助治疗.
结论:
- 新型疗法和神经调节技术通过准特定的分子通路显示出有前途.
- 将机械学理解与病理生理学的整合是开发精确,多式模式抑郁症治疗的关键.
- 需要进一步的研究来完善这些有针对性的策略,以改善患者的治疗结果.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
797
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
797
01:25Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
502
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
502
01:26Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:28Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239